We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
BLUJEPA GlaxoSmithKline Australia Pty Ltd
Product name
BLUJEPA
Accepted date
Jun-2025
Active ingredients
gepotidacin mesilate dihydrate
Proposed indication
BLUJEPA (gepotidacin mesilate dihydrate) is for the treatment of urinary tract infections in females.
Application type
A (new medicine)
Publication date
Jun-2025